Save as PDF

A Marketing Authorisation Application (MAA) needs to be filed to local or European authorities in order to gain market approval for a newly developed medicinal product.

Filing an MAA in eCTD format has become mandatory in many European countries, including applications using the Centralised Procedure (CP) to EMA. "eCTD only" submissions will become compulsory in all European countries in the near future.

Different electronic portals are available for the submission of applications via CP in electronic format to EMA (eSubmission Gateway/eSubmission Web Client) or for submission via mutual recognition or decentralised procedure (MRP/DCP) to national authorities using the Common European Submission Platform (CESP). As a consultancy, ERA is fully versed in using both submission portals and holds the required credentials to complete submissions through the ESG on behalf of clients.

ERA can support you in understanding and fulfilling the various agencies' requirements for filing submissions to EMA and/or local authorities as well as conducting the complete preparation and electronic submission (via CD or electronic portal) of an MAA in eCTD format.

How can ERA's eCTD group help?

Are you looking for other product development consulting services independent of eCTD?

For further information on other consulting services please see: